Breethe Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A

Breethe General Information

Description

Developer of medical devices designed to offer wearable ambulatory artificial lungs. The company's devices help to improve the outcomes of those who suffer from acute and chronic lung problems, enabling physicians to treat end-stage lung failure that has limited treatments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Abiomed
Primary Office
  • 1500 Joh Avenue
  • Suite 190
  • Halethorpe, MD 21227
  • United States
+1 (410) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Breethe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 30-Apr-2020 000.00 Completed Generating Revenue
7. Later Stage VC 09-Jul-2019 000 000.00 Completed Generating Revenue
6. Early Stage VC 26-Sep-2018 00.000 000.00 000.00 Completed Generating Revenue
5. Seed Round 19-Dec-2017 000 00.000 0000 Completed Generating Revenue
4. Seed Round 24-Aug-2017 00.000 00.000 000.00 Completed Generating Revenue
3. Seed Round 15-Aug-2016 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 03-Sep-2015 $575K $1.39M 000.00 Completed Generating Revenue
1. Seed Round 23-Jan-2015 $810K $810K 000.00 Completed Generating Revenue
To view Breethe’s complete valuation and funding history, request access »

Breethe Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 6 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series 5 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Seed-4 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Seed-3 000,000 00.000000 00.0 00.0 00 00.0 0.00
Seed-2 1,510,697 $0.000001 $1.87 $1.87 1x $1.87 6.51%
Seed 1,546,216 $0.000001 $1.48 $1.48 1x $1.48 6.66%
To view Breethe’s complete cap table history, request access »

Breethe Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Breethe Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Abell Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
UM Ventures Venture Capital Minority 000 0000 000000 0
To view Breethe’s complete investors history, request access »